Healthcare & Pharmaceuticals Industry Press Releases

Published on January 27, 2023 - 14:59 GMT

Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human ...

Docket Number: FDA-2015-D-1211 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research We, FDA, are issuing this draft guidance to receive comments on revised recommendations for evaluating donor eligibility using individual risk- …

Distribution channels:

Published on January 27, 2023 - 14:59 GMT

Blood Guidances

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 27, 2023 - 14:59 GMT

FDA Proposes Individual Risk Assessment for Blood Donations, While Continuing to Safeguard U.S. Blood Supply

For Immediate Release: January 27, 2023 The U.S. Food and Drug Administration today announced it is proposing a change from time-based deferrals to assessing blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk …

Distribution channels:

Published on January 27, 2023 - 14:02 GMT

FDA Proposes Individual Risk Assessment for Blood Donations, While Continuing to Safeguard U.S. Blood Supply

For Immediate Release: January 27, 2023 The U.S. Food and Drug Administration today announced it is proposing a change from time-based deferrals to assessing blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 27, 2023 - 14:00 GMT

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS ...

PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, and Neurochase, a company …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 27, 2023 - 13:47 GMT

Altamira Therapeutics Provides Business Update

HAMILTON, BERMUDA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Process for divestiture / partnering of legacy assets continues Strong data from Bentrio® NASAR study reinforces its therapeutic benefit for allergic rhinitis Case for Bentrio’s protective effect in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 27, 2023 - 13:45 GMT

Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Medsafe in New Zealand has granted approval to VAZKEPA (icosapent ethyl) to reduce the risk of cardiovascular (CV) events in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 27, 2023 - 13:32 GMT

Brachytherapy Market Is Expected to Generate USD 1.6 Billion by 2031, Says Allied Market Research

Portland, OR, Jan. 27, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global brachytherapy market garnered $0.83 billion in 2021, and is estimated to generate $1.6 billion by 2031, manifesting a CAGR of 7.1% from …

Distribution channels: Book Publishing Industry, Business & Economy ...

Published on January 27, 2023 - 13:30 GMT

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data at the Inaugural Molecular Glue Drug Development Summit

Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better performance than standard-of-care treatment Company plans to submit an Investigational New Drug …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on January 27, 2023 - 13:20 GMT

Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement

LOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 27, 2023 - 13:00 GMT

Orchestra BioMed Debuts as Nasdaq-Traded Company with Lead Programs Targeting Hypertension and Artery Disease and Novel ...

Business combination with Health Sciences Acquisitions Corporation 2, a special purpose acquisition company sponsored by an affiliate of RTW Investments, LP, completed on January 26, 2023 The combination was announced simultaneously with Orchestra’s …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 27, 2023 - 12:48 GMT

Organic Remedies Launches New Medical Marijuana Brand Product Line Through Exclusive Partnership With Former Steelers Linebacker ...

CARLISLE, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Organic Remedies, a medical marijuana cultivation and research organization based in south central Pennsylvania, has announced the official launch of its Steel City Greats Ryan Shazier brand product line. …

Distribution channels:

Published on January 27, 2023 - 12:30 GMT

Arbutus Announces Resignation of Board Member

WARMINSTER, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on January 27, 2023 - 12:29 GMT

Sol-Gel Announces Aggregate $22.8 Million Concurrent Registered Direct and Private Placement Offerings

NESS ZIONA, Israel, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a dermatology company with FDA approvals for EPSOLAY® and TWYNEO®, two innovative dermatology products that were launched in the U …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 27, 2023 - 12:00 GMT

Positive CHMP opinion for darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate ...

ORION CORPORATION PRESS RELEASE 27 January 2023 at 14:00 EET Positive CHMP opinion for darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer CHMP recommendation is based on the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 27, 2023 - 12:00 GMT

Euroopan lääkeviraston ihmislääkekomitealta (CHMP) myönteinen lausunto darolutamidin käytölle yhdessä dosetakselin kanssa ...

ORION OYJ LEHDISTÖTIEDOTE 27.1.2023 klo 14.00 Euroopan lääkeviraston ihmislääkekomitealta (CHMP) myönteinen lausunto darolutamidin käytölle yhdessä dosetakselin kanssa levinneen hormonisensitiivisen eturauhassyövän …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 27, 2023 - 12:00 GMT

Sol-Gel Acquires Patidegib, a Phase 3, FDA-Breakthrough-Designated Orphan Product Candidate to Pursue Potential Market of Over $...

Patidegib, an Orphan Drug candidate, broadens Sol-Gel’s pipeline with the potential to be the first therapy for preventing new basal cell carcinomas in Gorlin syndrome, if approved by the FDA Phase 3 study expected to initiate in the second half of 2023, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 26, 2023 - 23:31 GMT

CHERWITZ GRANTED PERMISSION TO JOIN DEFAMATION SUIT AGAINST BBC OVER RECKLESS PODCAST ABOUT WELLNESS COMPANY ONETASTE

OneTaste Sales Director Rachel Cherwitz was granted permission to join existing defamation claims against BBC Defamation Claims by IOM and OM IP Co continue NEW YORK, NY, USA, January 26, 2023 /⁨EINPresswire.com⁩/ -- * OneTaste Sales Director Rachel …

Distribution channels: Book Publishing Industry, Business & Economy ...

Published on January 27, 2023 - 11:00 GMT

GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered ...

STAMFORD, Conn., Jan. 27, 2023 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (Nasdaq: WGS) today announced the pricing of offerings for an aggregate of 428,571,429 shares of its Class A common stock at a public offering price of $0.35 per share (the “Offerings …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 27, 2023 - 10:00 GMT

Every Drop Counts: Medela Partners with World-Class Fitness Trainer Kayla Itsines to Bring Awareness to the Commitment Breast Milk ...

Baar, Switzerland, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms[1], announced a social collaboration with fitness trainer and global influencer Kayla Itsines to support her breastfeeding journey with her second baby, born …

Distribution channels: Companies, Culture, Society & Lifestyle ...

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire